Delivery dilemmas: how drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement

Cryptomarkets represent an important drug market innovation by bringing buyers and sellers of illegal drugs together in a ‘hidden’ yet public online marketplace. We ask: How do cryptomarket drug sellers and buyers perceive the risks of detection and arrest, and attempt to limit them?

Guardado en:  
Detalles Bibliográficos
Autor principal: Aldridge, Judith 1963- (Autor)
Otros Autores: Askew, Rebecca
Tipo de documento: Electrónico Artículo
Lenguaje:Inglés
Publicado: 2017
En: International journal of drug policy
Año: 2017, Volumen: 41, Páginas: 101-109
Acceso en línea: Presumably Free Access
Volltext (Resolving-System)
Journals Online & Print:
Gargar...
Verificar disponibilidad: HBZ Gateway
Palabras clave:

MARC

LEADER 00000naa a2200000 4500
001 1671662490
003 DE-627
005 20190820115841.0
007 cr uuu---uuuuu
008 190820s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.drugpo.2016.10.010  |2 doi 
035 |a (DE-627)1671662490 
035 |a (DE-599)KXP1671662490 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Aldridge, Judith  |d 1963-  |e VerfasserIn  |0 (DE-588)1011596105  |0 (DE-627)65886680X  |0 (DE-576)179135783  |4 aut 
109 |a Aldridge, Judith 1963- 
245 1 0 |a Delivery dilemmas  |b how drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement  |c Judith Aldridge, Rebecca Askew 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Cryptomarkets represent an important drug market innovation by bringing buyers and sellers of illegal drugs together in a ‘hidden’ yet public online marketplace. We ask: How do cryptomarket drug sellers and buyers perceive the risks of detection and arrest, and attempt to limit them? 
700 1 |a Askew, Rebecca  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of drug policy  |d Amsterdam [u.a.] : Elsevier Science, 1998  |g 41(2017), Seite 101-109  |h Online-Ressource  |w (DE-627)320482693  |w (DE-600)2010000-0  |w (DE-576)259271349  |x 1873-4758  |7 nnns 
773 1 8 |g volume:41  |g year:2017  |g pages:101-109 
856 |u https://doi.org/10.1016/j.drugpo.2016.10.010  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via crossref license)] 
856 4 0 |u http://dx.doi.org/10.1016/j.drugpo.2016.10.010  |x Resolving-System  |3 Volltext 
951 |a AR 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 3507716836 
LOK |0 003 DE-627 
LOK |0 004 1671662490 
LOK |0 005 20190820115841 
LOK |0 008 190820||||||||||||||||ger||||||| 
LOK |0 040   |a DE-21-110  |c DE-627  |d DE-21-110 
LOK |0 689   |a s  |a Drug markets 
LOK |0 689   |a s  |a Cryptomarkets 
LOK |0 689   |a s  |a Darknet drug markets 
LOK |0 689   |a s  |a Drug dealing 
LOK |0 689   |a s  |a Risk taking 
LOK |0 689   |a s  |a Risk reduction 
LOK |0 689   |a s  |a Law enforcement 
LOK |0 689   |a s  |a Darknet 
LOK |0 852   |a DE-21-110 
LOK |0 852 1  |9 00 
LOK |0 935   |a krub 
OAS |a 1 
ORI |a SA-MARC-krimdoka001.raw